David Piacquad is SVP, Business Development of AMGEN INC. Currently has a direct ownership of 44,787 shares of AMGN, which is worth approximately $13.9 Million. The most recent transaction as insider was on May 03, 2021, when has been sold 220 shares (Common Stock) at a price of $239.64 per share, resulting in proceeds of $52,721. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.8K
0% 3M change
0% 12M change
Total Value Held $13.9 Million

David Piacquad Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 03 2021
SELL
Payment of exercise price or tax liability
$52,721 $239.64 p/Share
220 Reduced 0.49%
44,787 Common Stock
May 01 2021
SELL
Payment of exercise price or tax liability
$33,310 $239.64 p/Share
139 Reduced 0.31%
45,007 Common Stock
Apr 30 2021
BUY
Grant, award, or other acquisition
-
709 Added 1.55%
45,146 Common Stock
Apr 27 2021
SELL
Payment of exercise price or tax liability
$32,707 $255.52 p/Share
128 Reduced 0.29%
44,437 Common Stock
Mar 19 2021
SELL
Payment of exercise price or tax liability
$242,220 $244.42 p/Share
991 Reduced 2.18%
44,565 Common Stock
Mar 02 2021
BUY
Grant, award, or other acquisition
-
2,648 Added 5.5%
45,504 Common Stock
May 05 2020
BUY
Grant, award, or other acquisition
-
1,269 Added 2.88%
42,773 Common Stock
May 03 2020
SELL
Payment of exercise price or tax liability
$31,413 $230.98 p/Share
136 Reduced 0.33%
41,504 Common Stock
May 01 2020
SELL
Payment of exercise price or tax liability
$29,424 $239.22 p/Share
123 Reduced 0.29%
41,640 Common Stock
Apr 27 2020
SELL
Payment of exercise price or tax liability
$27,408 $236.28 p/Share
116 Reduced 0.28%
41,763 Common Stock
Mar 20 2020
SELL
Payment of exercise price or tax liability
$316,227 $198.76 p/Share
1,591 Reduced 3.66%
41,879 Common Stock
Mar 03 2020
BUY
Grant, award, or other acquisition
-
3,711 Added 7.88%
43,411 Common Stock
Feb 06 2020
SELL
Open market or private sale
$2,130,071 $229.93 p/Share
9,264 Reduced 18.92%
39,700 Common Stock
Dec 13 2019
SELL
Payment of exercise price or tax liability
$572,276 $235.99 p/Share
2,425 Reduced 4.72%
48,964 Common Stock
Dec 13 2019
SELL
Exercise of conversion of derivative security
$467,475 $162.6 p/Share
2,875 Reduced 5.3%
51,389 Common Stock
Nov 20 2019
SELL
Payment of exercise price or tax liability
$1,093,315 $224.5 p/Share
4,870 Reduced 9.13%
48,491 Common Stock
Nov 20 2019
BUY
Exercise of conversion of derivative security
$898,856 $156.35 p/Share
5,749 Added 9.73%
53,361 Common Stock
May 03 2019
SELL
Payment of exercise price or tax liability
$32,123 $176.5 p/Share
182 Reduced 0.4%
45,864 Common Stock
May 03 2019
BUY
Grant, award, or other acquisition
-
1,691 Added 3.43%
47,555 Common Stock
May 01 2019
SELL
Payment of exercise price or tax liability
$30,664 $179.32 p/Share
171 Reduced 0.37%
46,046 Common Stock
Mar 22 2019
SELL
Payment of exercise price or tax liability
$289,562 $191.89 p/Share
1,509 Reduced 3.16%
46,217 Common Stock
Mar 06 2019
BUY
Grant, award, or other acquisition
-
3,676 Added 7.16%
47,674 Common Stock
Jan 30 2019
SELL
Payment of exercise price or tax liability
$31,122 $192.11 p/Share
162 Reduced 0.37%
43,998 Common Stock
Nov 30 2018
SELL
Payment of exercise price or tax liability
$831,538 $202.37 p/Share
4,109 Reduced 9.11%
41,019 Common Stock
Nov 30 2018
BUY
Exercise of conversion of derivative security
$355,485 $54.69 p/Share
6,500 Added 12.59%
45,128 Common Stock

Also insider at

NMRA
Neumora Therapeutics, Inc.
DP

David Piacquad

SVP, Business Development
Thousand Oaks, CA

Track Institutional and Insider Activities on AMGN

Follow AMGEN INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

News

Receive news related to AMGEN INC

Track Activities on AMGN